167 related articles for article (PubMed ID: 19014942)
1. Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II.
Malamut G; Afchain P; Verkarre V; Lecomte T; Amiot A; Damotte D; Bouhnik Y; Colombel JF; Delchier JC; Allez M; Cosnes J; Lavergne-Slove A; Meresse B; Trinquart L; Macintyre E; Radford-Weiss I; Hermine O; Brousse N; Cerf-Bensussan N; Cellier C
Gastroenterology; 2009 Jan; 136(1):81-90. PubMed ID: 19014942
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometry for the assessment and monitoring of aberrant intraepithelial lymphocytes in non-responsive celiac disease and non-celiac enteropathies.
Schiepatti A; Maimaris S; Scarcella C; Pignatti P; Betti E; Shoval Y; Arpa G; Ciccocioppo R; Biagi F
Dig Liver Dis; 2024 May; 56(5):795-801. PubMed ID: 37968145
[TBL] [Abstract][Full Text] [Related]
3. ACG clinical guidelines: diagnosis and management of celiac disease.
Rubio-Tapia A; Hill ID; Kelly CP; Calderwood AH; Murray JA;
Am J Gastroenterol; 2013 May; 108(5):656-76; quiz 677. PubMed ID: 23609613
[TBL] [Abstract][Full Text] [Related]
4. The incidence and clinical spectrum of refractory celiac disease in a north american referral center.
Roshan B; Leffler DA; Jamma S; Dennis M; Sheth S; Falchuk K; Najarian R; Goldsmith J; Tariq S; Schuppan D; Kelly CP
Am J Gastroenterol; 2011 May; 106(5):923-8. PubMed ID: 21468013
[TBL] [Abstract][Full Text] [Related]
5. Classification and management of refractory coeliac disease.
Rubio-Tapia A; Murray JA
Gut; 2010 Apr; 59(4):547-57. PubMed ID: 20332526
[TBL] [Abstract][Full Text] [Related]
6. Mucosal recovery and mortality in adults with celiac disease after treatment with a gluten-free diet.
Rubio-Tapia A; Rahim MW; See JA; Lahr BD; Wu TT; Murray JA
Am J Gastroenterol; 2010 Jun; 105(6):1412-20. PubMed ID: 20145607
[TBL] [Abstract][Full Text] [Related]
7. Open-Capsule Budesonide for Refractory Celiac Disease.
Mukewar SS; Sharma A; Rubio-Tapia A; Wu TT; Jabri B; Murray JA
Am J Gastroenterol; 2017 Jun; 112(6):959-967. PubMed ID: 28323276
[TBL] [Abstract][Full Text] [Related]
8. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease.
Husby S; Koletzko S; Korponay-Szabó IR; Mearin ML; Phillips A; Shamir R; Troncone R; Giersiepen K; Branski D; Catassi C; Lelgeman M; Mäki M; Ribes-Koninckx C; Ventura A; Zimmer KP; ; ;
J Pediatr Gastroenterol Nutr; 2012 Jan; 54(1):136-60. PubMed ID: 22197856
[TBL] [Abstract][Full Text] [Related]
9. Refractory Celiac Disease.
Malamut G; Cellier C
Gastroenterol Clin North Am; 2019 Mar; 48(1):137-144. PubMed ID: 30711206
[TBL] [Abstract][Full Text] [Related]
10. Celiac disease: a comprehensive current review.
Caio G; Volta U; Sapone A; Leffler DA; De Giorgio R; Catassi C; Fasano A
BMC Med; 2019 Jul; 17(1):142. PubMed ID: 31331324
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of Enteropathy-Associated T Cell Lymphoma.
Chander U; Leeman-Neill RJ; Bhagat G
Curr Hematol Malig Rep; 2018 Aug; 13(4):308-317. PubMed ID: 29943210
[TBL] [Abstract][Full Text] [Related]
12. Enteropathy associated T cell lymphoma in celiac disease: a large retrospective study.
Malamut G; Chandesris O; Verkarre V; Meresse B; Callens C; Macintyre E; Bouhnik Y; Gornet JM; Allez M; Jian R; Berger A; Châtellier G; Brousse N; Hermine O; Cerf-Bensussan N; Cellier C
Dig Liver Dis; 2013 May; 45(5):377-84. PubMed ID: 23313469
[TBL] [Abstract][Full Text] [Related]
13. NKp46 is a diagnostic biomarker and may be a therapeutic target in gastrointestinal T-cell lymphoproliferative diseases: a CELAC study.
Cheminant M; Bruneau J; Malamut G; Sibon D; Guegan N; van Gils T; Cording S; Trinquand A; Verkarre V; Lhermitte L; Brousse N; Jannot AS; Khater S; Frenzel L; Delarue R; Suarez F; Marçais A; Mulder CJ; Macintyre E; Asnafi V; Pouyet L; Bonnafous C; Lhospice F; Molina TJ; Meresse B; Cellier C; Cerf-Bensussan N; Hermine O;
Gut; 2019 Aug; 68(8):1396-1405. PubMed ID: 30448772
[TBL] [Abstract][Full Text] [Related]
14. Complications of coeliac disease.
Malamut G; Cellier C
Best Pract Res Clin Gastroenterol; 2015 Jun; 29(3):451-8. PubMed ID: 26060109
[TBL] [Abstract][Full Text] [Related]
15. Enteropathy-associated T-cell lymphoma: improving treatment strategies.
Nijeboer P; Malamut G; Mulder CJ; Cerf-Bensussan N; Sibon D; Bouma G; Cellier C; Hermine O; Visser O
Dig Dis; 2015; 33(2):231-235. PubMed ID: 25925928
[TBL] [Abstract][Full Text] [Related]
16. Type II enteropathy-associated T-cell lymphoma: a multicenter analysis from the Asia Lymphoma Study Group.
Tse E; Gill H; Loong F; Kim SJ; Ng SB; Tang T; Ko YH; Chng WJ; Lim ST; Kim WS; Kwong YL
Am J Hematol; 2012 Jul; 87(7):663-8. PubMed ID: 22641357
[TBL] [Abstract][Full Text] [Related]
17. How I treat enteropathy-associated T-cell lymphoma.
Di Sabatino A; Biagi F; Gobbi PG; Corazza GR
Blood; 2012 Mar; 119(11):2458-68. PubMed ID: 22271451
[TBL] [Abstract][Full Text] [Related]
18. Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project.
Delabie J; Holte H; Vose JM; Ullrich F; Jaffe ES; Savage KJ; Connors JM; Rimsza L; Harris NL; Müller-Hermelink K; Rüdiger T; Coiffier B; Gascoyne RD; Berger F; Tobinai K; Au WY; Liang R; Montserrat E; Hochberg EP; Pileri S; Federico M; Nathwani B; Armitage JO; Weisenburger DD
Blood; 2011 Jul; 118(1):148-55. PubMed ID: 21566094
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Cladribine treatment in refractory celiac disease type II.
Tack GJ; Verbeek WH; Al-Toma A; Kuik DJ; Schreurs MW; Visser O; Mulder CJ
World J Gastroenterol; 2011 Jan; 17(4):506-13. PubMed ID: 21274381
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation.
Sieniawski M; Angamuthu N; Boyd K; Chasty R; Davies J; Forsyth P; Jack F; Lyons S; Mounter P; Revell P; Proctor SJ; Lennard AL
Blood; 2010 May; 115(18):3664-70. PubMed ID: 20197551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]